PATRICK PARISI

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease SCHENECTADY, NY NPI 1649286170

General Payments — all program years on this page

$3,292.99

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 101
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,130.04 across 36 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $1,035.0535
Education $94.991

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $237.975
2019 $785.8017
2020 $116.343
2021 $139.877
2022 $412.1313
2023 $470.8420
2024 $1,130.0436

Records — PY2024 (36)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078905325 Actelion Pharmaceuticals US, Inc. $94.99 09/03/2024 Education Undisputed 01/23/2026 View at CMS
1081708699 Lexicon Pharmaceuticals, Inc. $16.86 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1081708701 Lexicon Pharmaceuticals, Inc. $18.42 07/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1081713552 Lexicon Pharmaceuticals, Inc. $18.54 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086117708 Bayer Healthcare Pharmaceuticals Inc. $18.69 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087228179 Novartis Pharmaceuticals Corporation $16.00 01/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087228183 Novartis Pharmaceuticals Corporation $26.28 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087228185 Novartis Pharmaceuticals Corporation $19.74 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087228187 Novartis Pharmaceuticals Corporation $17.65 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087228191 Novartis Pharmaceuticals Corporation $17.91 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087228193 Novartis Pharmaceuticals Corporation $0.87 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087228199 Novartis Pharmaceuticals Corporation $25.64 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087228203 Novartis Pharmaceuticals Corporation $21.13 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087228205 Novartis Pharmaceuticals Corporation $23.06 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087228217 Novartis Pharmaceuticals Corporation $1.07 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087228219 Novartis Pharmaceuticals Corporation $6.78 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087228223 Novartis Pharmaceuticals Corporation $0.58 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087228225 Novartis Pharmaceuticals Corporation $18.42 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087228231 Novartis Pharmaceuticals Corporation $24.65 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087228241 Novartis Pharmaceuticals Corporation $22.49 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101320526 E.R. Squibb & Sons, L.L.C. $12.71 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101320528 E.R. Squibb & Sons, L.L.C. $17.91 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101320534 E.R. Squibb & Sons, L.L.C. $124.76 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101320564 E.R. Squibb & Sons, L.L.C. $23.40 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101320570 E.R. Squibb & Sons, L.L.C. $132.95 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101320584 E.R. Squibb & Sons, L.L.C. $14.90 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104738171 AstraZeneca Pharmaceuticals LP $121.84 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105594141 AstraZeneca Pharmaceuticals LP $14.48 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105762204 AstraZeneca Pharmaceuticals LP $19.75 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115994271 Amgen Inc. $20.65 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118093876 Boehringer Ingelheim Pharmaceuticals, Inc. $18.66 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118093878 Boehringer Ingelheim Pharmaceuticals, Inc. $23.56 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119415834 Medtronic, Inc. $105.01 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131186341 PFIZER INC. $30.00 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131942547 PFIZER INC. $19.05 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132310545 SCPHARMACEUTICALS INC. $20.64 11/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.